Abbott Laboratories (NYSE:ABT)

61.71
Delayed Data
As of May 18
 +0.65 / +1.06%
Today’s Change
42.88
Today|||52-Week Range
64.60
+8.13%
Year-to-Date

Today’s Trading

Previous close61.06
Today’s open61.02
Day’s range60.94 - 61.87
Volume6,357,689
Average volume (3 months)6,804,647
Market cap$108.7B
Data as of 4:00pm ET, 05/18/2018

Growth & Valuation

Earnings growth (last year)-71.18%
Earnings growth (this year)+14.60%
Earnings growth (next 5 years)+12.65%
Revenue growth (last year)+31.35%
P/E ratio293.9
Price/Sales3.64
Price/Book3.50

Competitors

 Today’s
change
Today’s
% change
LLYEli Lilly and Co+0.41+0.50%
NVONovo Nordisk-0.27-0.55%
BMYBristol-Myers Squibb-0.03-0.06%
GSKGlaxoSmithKline-0.07-0.17%
Data as of 4:02pm ET, 05/18/2018

Financials

Next reporting dateJuly 18, 2018
EPS forecast (this quarter)$0.71
Annual revenue (last year)$27.4B
Annual profit (last year)$468.0M
Net profit margin1.26%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman &
Chief Executive Officer
Miles D. White
Chief Financial Officer &
Executive VP-Finance
Brian Bernard Yoor
Corporate headquarters
Abbott Park, Illinois

Forecasts